Active ingredientBromazepamCat. No. P-B114-001CAS 1812-30-2Family · Pharmaceutical analytical standards
Bromazepam
An intermediate-acting anxiolytic benzodiazepine, patented in 1961 and in clinical use since 1974: it is used mainly for severe anxiety and as premedication before minor surgery. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.
Did you know?Its name describes its chemistry: 'brom-' for the bromine atom and '-azepam' like many benzodiazepines; unlike diazepam, it carries a pyridine ring in place of a benzene ring.
Go to the active ingredient →Active ingredientBromazepamCat. No. P-B114-001CAS 1812-30-2
Pharmacopoeial impurityBromazepam EP Impurity ACat. No. P-B114-002CAS 1563-56-0
Pharmacopoeial impurityBromazepam EP Impurity BCat. No. P-B114-003CAS 41526-21-0
Pharmacopoeial impurityBromazepam EP Impurity CCat. No. P-B114-004CAS 868350-97-4
Pharmacopoeial impurityBromazepam EP Impurity DCat. No. P-B114-005CAS 77616-97-8
Pharmacopoeial impurityBromazepam EP Impurity ECat. No. P-B114-006CAS 1694-64-0
Isotopically labelledBromazepam-d4Cat. No. P-B114-007CAS 1185022-85-8
ImpurityBromazepam Impurity 1Cat. No. P-B114-008CAS 40951-53-9
Impurity2-(2-Aminobenzoyl)pyridineCat. No. P-B114-009CAS 42471-56-7
Impurity3-Hydroxy BromazepamCat. No. P-B114-010CAS 13132-73-5
ImpurityBromazepam N-OxideCat. No. P-B114-011CAS 1694-67-3No product matches your search.
EDQM standards 2
The official European Pharmacopoeia standards for this family.
Reference substanceBromazepam CRSEDQM code B1143000Family BromazepamNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.